LEZIONI DI CARDIOLOGIA

Pubblicazioni recenti

2000

in peer reviewed journals

De Caterina R: Endothelial dysfunctions: common denominators in vascular disease. Curr Opin Lipidol 2000; 11: 9-23.
De Caterina R: Endothelial dysfunctions: common denominators in vascular disease. Curr Opin Clin Nutr Metab Care 2000; 3: 453-467.
De Caterina R: Meno rischi dopo l'infarto. Efficace il trattamento con acidi grassi omega-3. Corriere della Sera 23 aprile 2000: 2.
De Caterina R: La familiarità per cardiopatia ischemica è associata a disfunzione endoteliale nel distretto coronarico. Ital Heart J 2000; 1: 571-572.
De Caterina R, Liao JK, Libby P: Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000; 71: 213S-223S.
De Caterina R, Basta G, Madonna R, Statile D, Zimarino M, Gallina S, Procopio AD: Endothelial cell transfections: a way for studying promoter activity of genes involved in atherogenesis. Ital Heart J 2000; 1: S55-S58.
Di Napoli P, Di Giovanni P, Muoio G, Gaeta MA, Taccardi AA, Rossi A, Calafiore AM, De Caterina R, Barsotti A, Ciglia C: Images in cardiovascular medicine. A case of free-floating left atrial thrombus in mitral valve stenosis. Ital Heart J 2000; 1: 500-501.
Limbruno U, Petronio AS, Amoroso G, Baglini R, Paterni G, Merelli A, Mariotti R, De Caterina R, Mariani M: The impact of coronary artery disease on coronary vasomotor response to non-ionic contrast media. Circulation 2000; 101: 491-497.
Limbruno U, Petronio AS, Baglini R, Mariani M, De Caterina R: Assessment of coronary vasomotor function: old and new tools. Ital Heart J 2000; 1: 258-263.
Limbruno U, Petronio AS, Baglini R, Mariani M, De Caterina R: Effetti vasomotori dei mezzi di contrasto angiografici iodati: un nuovo test per la valutazione della funzione endoteliale coronarica? Emodinamica 2000; 20: 6-9.
Simoncini T, Genazzani AR, De Caterina R: Towards a molecular understanding of the atheroprotective effects of estrogens: a review of estrogen effects on endothelial activation. Ital Heart J 2000; 1: 104-107.
Simoncini T, Maffei S, Basta G, Barsacchi G, Genazzani AR, Liao KL, De Caterina R: Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res 2000; 87: 19-25.
Zampolli A, Basta G, Lazzerini G, Feelisch M, De Caterina R: Inhibition of endothelial cell activation by nitric oxide donors. J Pharmacol Exp Ther 2000; 295: 818-823.
De Caterina R: Introduzione CORE - Combined Risk Evaluation, Aggiornamenti ottobre/dicembre 2000; 1(3): 4.
De Caterina R: Control of gene expression by fatty acids and lipids. ISSFAL 2000 Session Chairs Reports, ISSFAL Newsletter, Summer 2000, 7(2): 8-9.

in books and symposium proceedings (in extensu)

Zampolli A, De Caterina R: Meccanismi molecolari d’azione dei nitrovasodilatatori. In: L’Abbate A, Nitroderivati in cardiologia, I Quaderni del CNR, maggio 2000: 21-33.
De Caterina R, Basta G, Lazzerini G, Zimarino M, Gallina S: Meccanismi d’Azione dei Trigger Aterogeni. In: Rivascolarizzazione Miocardica, Concetti e Controversie, Cardiologia Invasiva Duemila 2000: 18-19.
De Caterina R: Acidi grassi polinsaturi n-3: i risultati nella prevenzione della restenosi da angioplastica coronarica: In: Cardiologia 1999. 2000: 326-340.
Basta G, De Caterina R: I prodotti di glicosilazione avanzata e la patogenesi dell'aterosclerosi accellerata nel diabete. In: De Caterina R (eds). Attivazione endoteliale e aterosclerosi (Primula ed.). 2000: 50-68.
De Caterina R, Libby P: L'attivazione endoteliale e la patogenesi dell'aterosclerosi: In: De Caterina R (eds). Attivazione endoteliale e aterosclerosi. (Primula ed. Pisa) 2000: 17-40.
De Caterina R: Infiammazione ed eventi precoci nell'aterogenesi: De Caterina R (eds). Attivazione endoteliale e aterosclerosi. (Primula ed. Pisa) 2000: 41-49.
De Caterina R: Acidi grassi n-3 e aterogenesi: effetti sulle interazioni endotelio-leucociti: In: De Caterina R (eds). Attivazione endoteliale e aterosclerosi. (Primula ed. Pisa) 2000: 84-99.
De Caterina R, Bernini W, Lenzi S: Il ruolo delle LDL nell'origine e nella progressione dell'aterosclerosi: In: De Caterina R (eds). Attivazione endoteliale e aterosclerosi. (Primula ed. Pisa). 2000: 142-151.
De Caterina R, Lenzi S: Prevenzione e terapia del danno vascolare e della disfunzione endoteliale con agenti ipocolesterolemizzanti: In: De Caterina R (eds). Attivazione endoteliale e aterosclerosi. (Primula ed. Pisa) 2000: 152-163.
De Caterina R, Patrono C: Atherothrombosis. Clinical Pharmacology: In: McGraw-Hill Clinical Medicine Series 2000: 751-769.
Gianetti J, Petronio AS, De Caterina R: Molecole di adesione in fase solubile come marcatori bioumorali di attivazione vascolare in vivo: In: De Caterina R (eds). Attivazione endoteliale e aterosclerosi. (Primula ed. Pisa) 2000: 164-176.
Lenzi S, Scanu AM, De Caterina R: La lipoproteina(a) come fattore di rischio aterotrombotico: evidenze epidemiologiche e possibili meccanismi patogenetici: In: De Caterina R (eds). Attivazione endoteliale e aterosclerosi. (Primula ed. Pisa) 2000: 100-117.
Simoncini T, Maffei S, De Caterina R: Terapia ormonale sostitutiva e rischio cardiovascolare: In: De Caterina R (eds). Attivazione endoteliale e aterosclerosi. (Primula ed. Pisa) 2000: 118-141.
Zampolli A, Lazzerini G, De Caterina R: Iperomocisteinemia e malattia vascolare: In: De Caterina R (eds). Attivazione endoteliale e aterosclerosi (Primula ed. Pisa) 2000: 69-83.

Edited Book

De Caterina R: Attivazione endoteliale e Aterosclerosi. Pisa: Primula Multimedia S.r.L., 2000.

2001

in peer reviewed journals

Barsotti A, Di Napoli P, Taccardi AA, Spina R, Stuppia L, Palka G, Barbacane RC, De Caterina R, Conti P: MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia. Atherosclerosis 2001; 155: 53-59.
Carluccio M, Vesentini N, De Caterina R: Recettori piastrinici di membrana e rischio cardiovascolare - dalla struttura alle possibili implicazioni cliniche. Ital Heart J 2001; 2: 733-747.
Carluccio M, Soccio M, De Caterina R: Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system. Eur J Clin Invest 2001; 31: 476-488.
Colombo MG, Citti L, Basta G, De Caterina R, Biagini A, Rainaldi G: Differential ability of human endothelial cells to internalize and express exogenous DNA. Cardiovasc Drugs and Ther 2001; 15: 25-29.
De Caterina R, Madonna R, Hassan J, Procopio AD: Nutriens and gene expression. World Rev Nutr Diet 2001; 89: 23-52.
De Caterina R, Basta G: n-3 fatty acids and the inflammatory response - biological background. Eur Heart J 2001; 3: D42-D49.
De Caterina R, Bourcier T, Laufs U, La Fata V, Lazzerini G, Neish AS, Libby P, Liao JK: Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-kappaB. Arterioscler Thromb Vasc Biol 2001; 21: 227-232.
De Caterina R: Commento a "Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice". Ital Heart J 2001; 2: 681-684.
De Caterina R, Ghiadoni L, Taddei S, Virdis A, Almerigogna F, Basta G, Lazzerini G, Bernini W, Salvetti A: Soluble E-selection in essential hypertension - a correlate of vascular structural changes. Am J Hypertens 2001; 14: 259-266.
De Caterina R, Zimarino M: The long-term use of blockers of the platelet ADP receptor in acute coronary syndromes. Haematologica 2001; 86: 25-27.
De Caterina R, Zampolli A: N-3 fatty acids: antiatherosclerotic effects. Lipids 2001; 36: S69-S78.
Di Napoli P, Taccardi AA, Grilli A, Spina R, Felaco M, Barsotti A, De Caterina R: Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts. Cardiovasc Res 2001; 51: 283-293.
Endres S, Berg Schmidt E, Krinstensen SD, De Caterina R: Vascular disease and nutrition. Lipids 2001; 36: S1-S2.
Gianetti G, De Caterina M, De Cristofaro T, Ungaro B, Del Guercio R, De Caterina R: Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease. Am Heart J 2001; 142: 733-739.
Iachini Bellisari F, Gallina S, De Caterina R: Tumor necrosis factor-alpha and cardiovascular diseases. Ital Heart J 2001; 2: 408-417.
Manca G, Parenti G, Bellina R, Boni G, Grosso M, Bernini W, Palombo C, Paterni M, Pelosi G, Lanza M, Mazzucca N, De Caterina R, Bianchi R: 111Indium platelet scintigraphy for the non-invasive detection of carotid plaque thrombosis. Stroke 2001; 32: 719-727.
Massaro M, De Caterina R: Effects of oleic acid on endothelial activation: a possible mechanism for prevention of atherosclerosis. Recent Research Development in Lipids 2001; 5: 85-96.
Pengo V, De Caterina R: Prevenzione del tromboembolismo nella fibrillazione atriale non reumatica. Un aggiornamento. Ital Heart J 2001; 2: 972-979.
Zimarino M, Cappelletti L, Venarucci V, Gallina S, Scarpignato M, Acciai N, Calafiore AM, Barsotti A, De Caterina R: Age-dependence of risk factors for carotid stenosis: an observational study among candidates for coronary arteriography. Atherosclerosis 2001; 159: 165-173.
Zimarino M, Pichard AD, De Caterina R, Calafiore AM: Percutaneous interventions on arterial conduits. J Invasive Cardiol 2001; 13: 114-120.
De Caterina R, Zimarino M: The long-term use of blockers of the platelet ADP receptor in acute coronary syndromes: In: Haematologica 2001. 2001: 25-27.
De Caterina R, Zampolli A: N-3 fatty acids: antiatherosclerotic effects: In: Lipids 2001. 2001: 69-78.
Endres S, Berg Schmidt E, Kristensen SD, De Caterina R: Vascular disease and nutrition: In: Lipids 2001. 2001: 1-2.

in books and symposium proceedings (in extensu)

De Caterina R: Strategie antitrombotiche combinate nelle malattie cardiovascolari: In: Relazioni Scientifiche "Aterotrombosi 2001".
De Caterina R: Endothelial dysfuntions common denominators in vascular disease: In: Russo F, Vetta F (eds). Ipertensione arteriosa: dall'istopatogenesi del danno d'organo agli eventi clinici maggiori. 2001: 141-164.
De Caterina R: Olive oil and early atherogenesis: the important contribution of oleic acid: In: Abstracts Book International Congress Olive Oil. 2001: 33-36.
Di Gioacchino L, De Caterina R: Il trattamento delle sindromi coronariche acute oltre la fase acuta: In: Cardiologia 2001 - 35° Convegno Internazionale del Dipartimento Cardio-Toraco-Vascolare A. De Gasperis. 2001: 115-127.
Epistolato MC, Mazzone A, Biagini A, Gianetti J, Cetta S, Schufeld K, De Caterina R, Tanganelli P: Aspetti morfo-funzionali nelle lesioni aterosclerotiche carotidee (correlazioni tra neoangiogenesi, espressione di molecole di adesione e flogosi): In: Atti del III Meeting Regionale Toscano della S.I.S.A. 2001: 1-7.
Massaro M, De Caterina R: La dieta mediterranea: basi epidemiologiche per la cardioprotezione e meccanismi biologici: In: Conoscere e Curare il Cuore 2001 - Atti del XVIII Simposio del Centro per la Lotta contro l'Infarto. 2001: 75-93.

Edited Books

Endres S, Schmidt EB, Kristensen SD, De Caterina R: Prevention and Treatment of Vascular Disease - a Nutrition-Based Approach. Lipids 2001; AOCS Press, 2001: S1-S130.

2002

in peer reviewed journals

Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, De Caterina R: Advanced glycation end products (AGEs) activate endothelium via RAGE: a mechanism for amplification of inflammatory responses. Circulation 2002; 105: 816-822.
De Caterina R, Renda G: Connivenze tra cuore e cervello. Un ictus su tre viene dal cuore. Atti del XIX Simposio del Centro per la lotta contro l'infarto - Conoscere e Curare il Cuore 2002; 9-20.
De Caterina R, Madonna R: Effetti antiaritmici degli acidi grassi omega-3 - una rassegna. Ital Heart J 2002; 3: 297-308.
De Caterina R, Cipollone F, Filardo FP, Zimarino M, Bernini W, Lazzerini G, Bucciarelli T, Falco A, Marchesani P, Muraro R, Mezzetti A, Ciabattoni G: Low-density lipoprotein level reduction by the 3-hydraxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. Circulation 2002; 106: 2543-2549.
Di Napoli P, Taccardi AA, De Caterina R, Barsotti A: Pathophysiology of ischemia-reperfusion injury: experimental data. Ital Heart J 2002; 3: 24S-28S.
Di Napoli P, Taccardi AA, Di Gioacchino L, De Caterina R, Barsotti A: Regulation of endothelial function in coronary microcirculation by HMG-CoA reductase drugs. Ital Heart J 2002; 3: 20S-23S.
Di Napoli P, Taccardi AA, Oliver M, De Caterina R: Statins and stroke: evidence for cholesterol-independent effects. Eur Heart J 2002; 23: 1908-1921.
Di Napoli P, Taccardi AA, Grilli A, Felaco M, Di gioacchino L, De Caterina R, Barsotti A: Verapamil reduces coronary endothelium damage and cardiomyocyte necrosis but no apoptosis after ischemia and reperfusion: ex-vivo study in rat hearts. Int J Immunopathol Pharmacol 2002; 15: 225-232.
Gianetti J, Bevilacqua S, De Caterina R: Inhaled nitric oxide: more than a selective pulmonary vasodilator. Eur J Clin Invest 2002; 32: 628-635.
Gianetti J, Lazzerini G, Bernini W, Basta G, Pedrinelli R, Petrucci R, De Cristofaro T, De Caterina R, Bellomo G: An inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. Am Heart J 2002; 143: 467-474.
Grimm M, Spiecker M, De Caterina R, Shin WS, Liao JK: Inhibition of MHC class II gene transcription by nitric oxide and antioxidants. J Biol Chem 2002; 277: 26460-26467.
Iachini Bellisari F, De Caterina R: Commento a: L'acido folico previene la tolleranza ai nitrati e la disfunzione endoteliale indotta dalla Nitroglicerina. L'informazione Cardiologica 2002; 22: 9-12.
Maresta A, Balduccelli M, Varani E, Marzilli M, Galli C, Heiman F, Lavezzari M, Stragliotto E, De Caterina R: Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the Esapent for Prevention of Restenosis Italian Study (ESPRIT). Am Heart J (Website) 2002; 143: 1-10.
Massaro M, Basta G, Lazzerini G, Carluccio MA, Bosetti F, Solaini G, Tongiani R, Paolicchi A, De Caterina R: Quenching of intracellular ROS generation as a mechanism for oleate-induced reduction of endothelial activation and early atherogenesis. Thromb Haemost 2002; 88: 335-344.
Massaro M, Carluccio MA, Paolicchi A, Bosetti F, Solaini G, De Caterina R: Mechanisms for reduction of endothelial activation by oleate: inhibition of nuclear factor-kappaB through antioxidant effects. Prostaglandins Leukot Essent Fatty Acids 2002; 67: 175-181.
Massaro M, De Caterina R: Vasculoprotective effects of oleic acid: epidemiological background and direct vascular antiatherogenic properties. Nutr Metab Cardiovasc Dis 2002; 12: 42-51.
Renda G, De Caterina R: Aspirina ed ACE-inibitori: una partita ancora aperta? La Cardiologia nella Pratica Clinica 2002; 9: 150-161.
Tavarozzi I, Comani S, Del Gratta C, Romani GL, Di Luzio S, Brisinda D, Gallina S, Zimarino M, Fenici R, De Caterina R: Magnetocardiography: current status and perspectives. Part I: Physical principles and instrumentation. Ital Heart J 2002; 3: 75-85.
Tavarozzi I, Comani S, Del Gratta C, Di Luzio S, Romani GL, Gallina S, Zimarino M, Brisinda D, Fenici R, De Caterina R: Magnetocardiography: current status and perspectives. Part II: Clinical applications. Ital Heart J 2002; 3: 151-165.
Zimarino M, Ajani AE, Marazia S, Pichard AD, Satler LF, De Caterina R, Barsotti A, Waksman R: Influence of device selection on angiographic outcomes for the treatment of in-stent restenosis. A sub analysis from the Washington Radiation for In-Stent restenosis Trial (WRIST). Ital Heart J 2002; 3: 256-262.
Zimarino M, Weissman NJ, Waksman R, De Caterina R, Ahmed JM, Pichard AD, Mintz GS: Analysis of stent edge restenosis with different forms of brachytherapy. Am J Cardiol 2002; 89: 322-325.

in books and symposium proceedings (in extensu)

De Caterina R, Renda G: Connivenze tra cuore e cervello. Un ictus su tre viene dal cuore: In: Conoscere e Curare il Cuore 2002 - Atti del XIX Simposio del Centro per la lotta contro l'infarto. 2002: 9-20.
De Caterina R: Effects of the block of HMG-CoA-Reductase on myocardial expression of the inducible nitric oxide synthase (iNOS): In: Riunione delle Unità Operative - Consorzio Interuniversitario per la Ricerca Cardiovascolare. 2002: 17-18.
De Caterina R: Dietary modulation of the inflammatory response: In: Brady H, Wilcox C (eds). Therapy of nephrology and hypertension: a companion to Brenner's the Kidney. 2002.
De Caterina R: Fasi inziali dell'aterogenesi e punti d'attacco per la prevenzione: In: De Caterina R (eds). Dieta mediterranea e cardioprotezione dalle evidenze epidemiologiche ai meccanismi di azione molecolare. (Primula 2002 ed.). 2002: 60-72.
Gabriele E, Zimarino M, Gallina S, De Caterina R: Fisiopatologia di base - Proteina C reattiva: In: Specchia G (eds). Mosby Year Book ANGINA PECTORIS 2001. (AstraZeneca ed.). 2002: 10-15.
Gianetti J, De Caterina R: Fisiopatologia di base - Molecole di adesione solubili: In: Specchia G (eds). Mosby Year Book ANGINA PECTORIS 2001. (AstraZeneca 2002 ed.). 2002: 7-10.
Del Turco S, De Caterina R: Fisiopatologia di base - Fattore tissutale: In: Specchia G (eds). Mosby Year Book ANGINA PECTORIS 2001. (AstraZeneca 2002 ed.). 2002: 15-19.
De Caterina R: Fisiopatologia di base - Biologia vascolare I: Trigger primari dell'aterogenesi: prodotti di glicazione avanzata ed LDL modificate: In: Specchia G (eds). Mosby Year Book ANGINA PECTORIS 2001. (AstraZeneca 2002 ed.). 2002: 147-156.
De Caterina R: Fisiopatologia di base - Biologia vascolare II: Peroxisome proliferator activated receptors , leptina e acidi grassi perossidati: In: Specchia G (eds). Mosby Year Book ANGINA PECTORIS 2001. (AstraZeneca 2002 ed.). 2002: 156-162.
De Caterina R: Fisiopatologia di base - Biologia vascolare III: Meccanismi molecolari di fattori di rischio cardiovascolare e nuovi marcatori: In: Specchia G (eds). Mosby Year Book ANGINA PETORIS 2001. (AstraZeneca 2002 ed.). 2002: 162-169.
De Caterina R: Fisiopatologia di base - Genetica: In: Specchia G (eds). Mosby Year Book ANGINA PECTORIS 2001. (AstraZeneca 2002 ed.). 2002: 169-175.
De Caterina R: Disfunzione endoteliale, infiammazione e aterogenesi: In: Salvetti A, Taddei S (eds). L'endotelio fisiopatologia e valore clinico - Monografia di Cardiologia. 2002: 120-134.
Filardo FP, Lenzi S, Ferdeghini EM, De Caterina R: Approccio integrato al paziente con fattori di rischio multipli: In: De Caterina R (eds). I fattori di rischio cardiovascolare - I Quaderni del CNR. (Primula 2002 ed.). 2002: 182-192.
L'Abbate A, De Caterina R: La valutazione clinica e di laboratorio del paziente con fattori di rischio: In: De Caterina R (eds). I fattori di rischio cardiovascolare. (Primula 2002 ed.). 2002: 26-30.
Madonna R, Torge G, Di Napoli P, De Caterina R: La sindrome da basse HDL: In: De Caterina R (eds). I fattori di rischio cardiovascolare - I Quaderni del CNR. (Primula 2002 ed.). 2002: 91-101.
Simoncini T, De Caterina R: Il sesso e il rischio cardiovascolare: In: De Caterina R (eds). I fattori di rischio cardiovascolare - I Quaderni del CNR. (Primula 2002 ed.). 2002: 47-54.
Zampolli A, De Caterina R: Meccanismi molecolari d'azione dei nitrovasodilatatori: In: L'Abbate A (eds). Nitroderivati in cardiologia - I Quaderni del CNR. (Primula 2002 ed.). 2002: 21-23.
Zampolli A, Madonna R, De Caterina R: Altri fattori di rischio: In: De Caterina R (eds). I fattori di rischio cardiovascolare - I Quaderni del CNR. (Primula 2002 ed.). 2002: 162-181.
Carluccio MA, Massaro M, De Caterina R: Effetti antiaterogeni diretti di componenti della dieta mediterranea: In: De Caterina R (eds). Dieta mediterranea e cardioprotezione dalle evidenze epidemiologiche ai meccanismi di azione molecolare. (Primula 2002 ed.). 2002: 73-81.
Carluccio M, De Caterina R: Storia familiare e rischio coronarico: In: De Caterina R (eds). I fattori di rischio cardiovascolare - I Quaderni del CNR. (Primula 2002 ed.). 2002: 31-43.
Carluccio M, De Caterina R: L'età come fattore di rischio coronarico: In: De Caterina R (eds). I fattori di rischio cardiovascolare - I Quaderni del CNR. (Primula 2002 ed.). 2002: 44-46.
Zampolli A, Lazzerini G, Basta G, Carluccio M, Soccio M, De Caterina R: Fisiopatologia di base - Genetica: In: Specchia G (eds). Mosby Year Book ANGINA PECTORIS 2001. (AstraZeneca 2002 ed.). 2002: 1-7.

Edited Books

De Caterina R: Dieta mediterranea e cardioprotezione dalle evidenze epidemiologiche ai meccanismi di azione molecolare - I Quaderni del CNR. Pisa: Primula Multimedia S.r.L., 2002.
L'Abbate A, De Caterina R: I fattori di rischio cardiovascolare - I Quaderni del CNR. Pisa: Primula Multimedia S.r.L., 2002.
Crea F, De Caterina R, De Servi S, Labellarte A, Lanza G.A, Marzilli M, Prati P: Angina Pectoris 2001 - Mosby Year Book. San Giuliano Milanese (MI): Mosby Italia Srl, 2002.

2003

in peer reviewed journals

Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, Visioli F, Distante A, De Caterina R: Olive oil and red wine antioxidant polyphenols inhibit endothelial activation. Antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscer Thromb Vasc Biol 2003; 23: 622-629.
De Caterina R: Low-dose aspirin in primary prevention of cardiovascular disease: how to balance the benefit and the risk. Ital Heart J 2003; 4: 228-231.
De Caterina R, Madonna R, Zucchi R, La Rovere MT: Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside. Am Heart J 2003; 146: 420-430.
De Caterina R, Manes C: Inflammation in early atherogenesis: impact of ACE inhibition. Eur Heart J 2003; 5: A15-A24.
De Caterina R: La combinazione di aspirina e clopidogrel nelle situazioni cliniche ad alto rischio. Cuore e Vasi 2003; 4.
De Caterina R, Di Gioacchino L: Glycoprotein IIb-IIIa inhibitors in unstable coronary syndromes and percutaneous inteventions - a conservative approach. Revista Portuguesa de Cardiologia 2003; 22: 995-1002.
De Caterina R: Aspirina a basse dosi nella prevenzione primaria delle malattie cardiovascolari. Come bilanciare rischi e benefici. Medico e Paziente 2003; 17-20.
Del Turco S, De Caterina R: Biologia e fisiopatologia del fattore tissutale e sua rilevanza per la patologia cardiovascolare. Ital Heart J 2003; 4: 559-568.
Di Napoli P, Taccardi AA, Grilli A, Felaco M, Balbone A, Angelucci D, Gallina S, Calafiore AM, De Caterina R, Barsotti A: Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients whit severe dilated cardiomyopathy. Am Heart J 2003; 146: 1105-11.
Falcone A, Ranalli G, Luise R, Di Gianmarco G, De Caterina R, Mobilij A: Caso clinico di significativo "reverse remodeling" dopo terapia di resincronizzazione cardiaca. Ital Heart J 2003; 4: 337-339.
Grilli A, Lutiis MA, Patruno A, Speranza L, Gizzi F, Taccardi AA, Di Napoli P, De Caterina R, Conti P, Felaco M: Inducible nitric oxide synthase and heme oxygenase-1 in rat heart: direct effect of chronic exposure to hypoxia. Ann Clin Lab Sci 2003; 33: 208-215.
Grilli A, De Lutiis MA, Patruno A, Speranza L, Cataldi A, Taccardi AA, Di Napoli P, De Caterina R, Barbacane R, Conti P, Felaco M: Effect of chronic hypoxia on inducible nitric oxide synthase expression in rat myocardial tissue. Exp Biol Med 2003; 228: 935-942.
Iachini Bellisarii F, Gallina S, Zimarino M, De Caterina R: Mechanisms of nitrate tolerance: potential roles of folate. Eur J Clin Invest 2003; 33: 933-940.
Limbruno U, De Caterina R: Vasomotor effects of iodinated contrast media: just side effects? Current Vascular Pharmacology 2003; 1: 321-328.
Massaro M, De Caterina R: Effetti antiaterogeni dell'acido oleico. Agg. Med. 2003; 4: 1-10.
Renda G, Sciartilli A, De Caterina R: Aspirin resistance. Journal of Hematology 2003; 88: 43-49.
Renda G, De Caterina R: Le eparine: da non frazionate a basso peso molecolare. Struttura e mecanismo d’azione. Primary Cardiology 2003; 169-179.
Soccio M, D'Ambrosio C, De Caterina R: L'emolisi dopo chirurgia vascolare. Ital Heart J Suppl 2003; 4: 807-813.
The EUROPA Study Investigators: Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). The Lancet 2003; 362: 782-788.
Volpe S, Marrone G, Renda G, Spina R, Gallina S, Marchetti A, Paloscia L, Di Giammarco G, Calafiore A, De Caterina R: Images in cardiovascular medicine. Membrane-type subaortic stenosis in the adult. Italian Heart Journal 2003; 4: 651-652.
Zimarino M, Gallina S, De Caterina R: Detrimental effects of late artery opening. J Am Coll Cardiol 2003; 41: 1067-1068.

in books and symposium proceedings (in extensu)

Barsotti A, Di Napoli P, Taccardi A, Statile D, Gaeta M, Gallina S, De Caterina R: Danno coronarico dopo ischemia-riperfusione: variazioni indotte dall'età nel cuore di ratto: In: Dagianti A (eds). Attualità in tema di cardiopatia ischemica giovanile. CIC Edizioni Internazionali; 2003: 65-76.
De Caterina R, Zampolli A: Acidi grassi n-3: effetti sull'aterosclerosi: In: Edizioni Scientifiche. Omega-3 e riduzione del rischio cardiovascolare, 2003: 65-87.
De Caterina R, Libby P: Arteriosclerosi: basi molecolari e meccanismi d'azione dei fattori di rischio: In: Medicina Clinica Basi Biologiche Diagnostica Terapia. Torino: C.G.Edizioni Medico Scientifiche, 2003: 1-28.
De Caterina R, Manes C, Zampolli A: PUFA n-3: effetti antiaterogeni: In: Società Italiana di Farmacologia (ed). La Farmacologia dei PUFA n-3: dall'igloo al laboratorio alla pratica clinica. Milano, 2003: 29-52.
De Caterina R: Antiaggreganti vecchi o nuovi?: In: De Biase AM, Lombardo M, Roghi A, Tarelli G, Bruschi G (eds). Controversie in Cardiologia. Incontri con gli esperti. Andrea Tencati Editore srl, 2003: 295-303.

2004

in peer-reviewed journals

· ADDIN EN.REFLIST Zimarino M, Gallina S, Di Fulvio M, Di Mauro M, Di Giammarco G, De Caterina R, Calafiore AM. Intraoperative ischemia and long-term events after minimally invasive coronary surgery. Ann Thorac Surg. 2004;78:135-41.

· Lorenzoni R, Lazzerini G, Cocci F, De Caterina R. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study. Am Heart J. 2004;148:e6.

· Comani S, Gallina S, Lagatta A, Orlandi M, Morana G, De Luzio S, Brisinda D, De Caterina R, Fenici R, Romani GL. Concentric remodeling detection by magnetocardiography in patients with recent onset arterial hypertension. Pacing Clin Electrophysiol. 2004;27:709-18.

· De Caterina R, Zampolli A, Madonna R, Fioretti P, Vanuzzo D. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism. Ital Heart J. 2004;5 Suppl 6:19S-24S.

· Mazzone A, Epistolato MC, De Caterina R, Storti S, Vittorini S, Sbrana S, Gianetti J, Bevilacqua S, Glauber M, Biagini A, Tanganelli P. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. J Am Coll Cardiol. 2004;43:1670-6.

· Zimarino M, De Caterina R. Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: Part 2: When and how to use various agents. J Cardiovasc Pharmacol. 2004;43:477-84.

· Zimarino M, De Caterina R. Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: part 1: the evidence of benefit. J Cardiovasc Pharmacol. 2004;43:325-32.

· Basta G, Del Turco S, De Caterina R. [Advanced glycation endproducts and vascular inflammation: implications for accelerated atherosclerosis in diabetes]. Recenti Prog Med. 2004;95:67-80.

· Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia. 2004;47:532-6.

· Patrono C, Bachmann F, Baigent C, Bode C, De Caterina R, Charbonnier B, Fitzgerald D, Hirsh J, Husted S, Kvasnicka J, Montalescot G, Garcia Rodriguez LA, Verheugt F, Vermylen J, Wallentin L, Priori SG, Alonso Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Fernandez Burgos E, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Ferreira R, Steg PG, Teixeira F, Wilcox R. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J. 2004;25:166-81.

· De Caterina R, Zampolli A. From asthma to atherosclerosis--5-lipoxygenase, leukotrienes, and inflammation. N Engl J Med. 2004;350:4-7.

· Renda G, De Caterina R: La profilassi antitrombotica nel soggetto anziano con fibrillazione atriale. It J Practice Cardiol 2004; 1: 33-37.

in books or symposium proceedings (in extensu)

· Massaro M, Carluccio M, Ancora M, Scoditti E, De Caterina R: Vasculoprotective effects of olive oil: background and direct vascular antiatherogenic properties: In: Watson R, Preedy V (eds). Nutrition and Heart Disease Causation and Prevention. CRC Press, 2004: 193-213.

· De Caterina R, Gianetti J: Bypass aorto-coronarico e terapia interventistica. In: Carpi C, Ferrari R, Ledda F, Patrono C, Tremoli E (eds). Farmaci per la terapia cardiovascolare - Trattato di Farmacologia e Terapia (UTET ed.) 2004

· De Caterina R, Gianetti I: Infarto miocardico acuto: In: Carpi C, Ferrari R, Ledda F, Patrono C, Tremoli E (eds). Farmaci per la terapia cardiovascolare - Trattato di Farmacologia e Terapia (UTET ed.) 2004

2005

· De Caterina R, Schmidt EB, Kristensen SD: n-3 fatty acids in the secondary prevention of coronary heart disease. E-Journal of Cardiology Practice; vol 3, n. 01. In: http://www.escardio.org/knowledge/cardiology_practice

· Kristensen SD, Huber K, De Caterina R: ST-elevation myocardial infarction – should choice of reperfusion therapy depend on duration of symptoms? E-Journal of Cardiology Practice; vol 3, n. 14. In: http://www.escardio.org/knowledge/cardiology_practice

· Huber K, De Caterina R, Kristensen SD: The immediate anti-thrombotic therapy in patients with acute coronary syndromes. E-Journal of Cardiology Practice; vol 3, n. 21. In: http://www.escardio.org/knowledge/cardiology_practice

· Schmidt EB, Arnesen H, De Caterina R, Rasmussen LH, Kristensen SD: Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety. Thrombosis Research 2005; 115: 163-170.

· Schmidt EB, Arnesen H, Christensen JH, Rasmussen LH, Kristensen SD, De Caterina R: Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part II. Clinical trials and recommendations. Thrombosis Research 2005; 115: 257-262.

· De Caterina R, Lorenzoni R: Reply to “Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not clear” by Jackson SL et al. Am Heart J 2005; 149: e4.

· Di Napoli P, Taccardi AA, Grilli A, De Lutiis MA, Barsotti A, Felaco M, De Caterina R: Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. Cardiovascular Research 2005 Jun 1; 66(3): 462-471.

· Limbruno U, De Carlo M, Pistolesi S, Micheli A, Petronio AS, Camacci T, Fontanini G, Balbarini A, Mariani M, De Caterina R: Distal embolization during primary angioplasty: Histopathologic features and predictability. American Heart Journal 2005 Jul; 150(1): 102-108.

· Granieri M, Iachini Bellisarii F, De Caterina R: Le vitamine del gruppo B come nuove variabili correlate al rischio cardiovascolare. Italian Heart Journal Suppl. 2005 Jan; 6(1): 1-16.

· Madonna R, Di Napoli P, Massaro M, Grilli A, Felaco M, De Caterina A, Daming T, De Caterina R, Geng YJ: Simvastatin attenuates expression of cytokine-inducible nitric oxide synthase in embryo cardiac myoblasts. J Biol Chem 2005 Apr 8; 280(14): 13503-13511.

· Zimarino M, De Caterina R: Commentary. Cardiovascular Medicine 2005; 9: 42-43.

· Zimarino M, Renda G, De Caterina R: Optimal duration of antiplatelet therapy in recipients of coronary drugeluting stents. Drugs 2005; 65(6): 725-732.

· Zimarino M, Calafiore AM, De Caterina R: Complete myocardial revascularization: between myth and reality. Eur Heart J 2005 Sep; 26(18): 1824-1830.

· Basta G, Lazzerini G, Del Turco S, Ratto GM, Schmidt AM, De Caterina R: At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol 2005 Jul; 25(7): 1401-7.

· Soccio M, Toniato E, Evangelista V, Carluccio M, De Caterina R: Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. European Journal of Clinical Investigation 2005; 35: 305-314.

· Zampolli A, Bysted A, Leth T, Mortesen A, De Caterina R, Falk E: Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. Atherosclerosis 2005 Jun 7

· De Carlo M, Limbruno U, Pistolesi S, Fontanini G, Petronio AS, Balbarini A, De Caterina R: Distal embolization during angioplasty for acute myocardial infarction: is pharmacological protection enough? Thrombosis and Haemostasis 2005 Sep; 94(3): 680-681.

· Butchart EG, Gohlke-Barwolf C, Antunes MJ, Tornos P, De Caterina R, Cormier B, Prendergast B, Iung B, Bjornstad H, Leport C, Hall RJ, Vahanian A: Recommendations for the management of patients after heart valve surgery. Eur Heart J 2005 Nov; 26(22): 2463-2471.

· Huber K, De Caterina R, Kristensen SD, Verheugt FW, Montalescot G, Maestro LB, Van de Werf F: Prehospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. Eur Heart J 2005 Oct; 26(19): 2063-2074.

· Renda G, De Caterina R: Limitazioni dei farmaci anticoagulanti orali nella profilassi tromboembolica della fibrillazione atriale e nuove prospettive. It J Practice Cardiol 2005; 2: 5-18.

· De Caterina R, Madonna R: Role of nutrients and physical activity in gene expression. World Rev Nutr Diet 2005; 94: 107-19.

· Zimarino M, Iachini Bellisarii F, Riccardi I, De Caterina R: La fisiopatologia delle occlusioni coronariche croniche e relative implicazioni nel trattamento percutaneo. Il Giornale Italiano di Cardiologia Invasiva 2005; 2: 22-30.

· Granieri M, Iachini Bellisarii F, De Caterina R: Vitamin B6, vitamin B12 and folate: New inverse correlates of cardiovascular risk. Heart International 2005; 1(1)

in books or symposium proceedings (in extensu)

· Renda G, De Caterina R: I nuovi farmaci antitrombotici cambieranno il trattamento della fibrillazione atriale? Stiamo per dire addio ai dicumarolici ed ai controlli di INR? In: Conoscere e Curare il Cuore 2005, Atti del XXII Simposio del Centro per la lotta contro l’infarto – Fondazione Onlus. Firenze, 25-27 febbraio 2005, pp. 289-319.

· De Caterina R, Zampolli A, Falk E: Dalla placca instabile agli eventi clinici. In: Ardissino D, De Caterina R, Lembo G, Manzato E, Prati F, Tanganelli P: Instabilità di placca ed eventi cardiovascolari. PPG Edizioni Scientifiche 2005; cap. 4, pp.75-103.

· Massaro M, Carluccio MA, Scoditti E, De Caterina R: Epidemiology of olive oil and cardiovascular disease. In: Quiles JL: Olive Oil and Health 2005

· Crea F, Camici PG, De Caterina R, Lanza GA: Chronic IHD (Part 1), cap. 14. In: Camm J, Luscher t, Serruys P: ESC Textbook of Cardiovascular Medicine, Blackwell Publishing 2005

Authored Books

· Ardissino D, De Caterina R, Lembo G, Manzato E, Prati F, Tanganelli P: Instabilità di placca ed eventi cardiovascolari. PPG (Pharma Project Group srl) Edizioni Scientifiche 2005

· Kristensen SD, De Caterina R, Moliterno DJ: Therapeutic Strategies in Thrombosis, Clinical Publishing 2005

· Bosica D, Tonti G, De Caterina R: La funzione diastolica, Elsevier Italia 2005.

2006

· De Caterina R, Zampolli A, Del Turco S, Madonna R, Massaro: Nutritional mechanisms that influence cardiovascular disease.Am J Clin Nutr. 2006 Feb;83(2):421S-426S. Review.

· Bellisarii FI, Marchetti M, Caputo M, De Caterina R.: Coronary arteriovenous fistula presenting as chronic pericardial effusion. J Cardiovasc Med (Hagerstown). 2006 Jun;7(6):449-53. PMID: 6721212 [PubMed - in process]

· The ACTIVE Steering Committee; ACTIVE Investigators; Connolly S, Yusuf S, Budaj A, Camm J, Chrolavicius S, Commerford PJ, Flather M, Fox KA, Hart R, Hohnloser S, Joyner C, Pfeffer M, Anand I, Arthur H, Avezum A, Bethala-Sithya M, Blumenthal M, Ceremuzynski L, De Caterina R, Diaz R, Flaker G, Frangin G, Franzosi MG, Gaudin C, Golitsyn S, Goldhaber S, Granger C, Halon D, Hermosillo A, Hunt D, Jansky P, Karatzas N, Keltai M, Lanas F, Lau CP, Le Heuzey JY, Lewis BS, Morais J, Morillo C, Oto A, Paolasso E, Peters RJ, Pfisterer M, Piegas L, Pipillis T, Proste C, Sitkei E, Swedberg K, Synhorst D, Talajic M, Tregou V, Valentin V, van Mieghem W, Weintraub W, Varigos J.: Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. Am Heart J. 2006 n;151(6):1187-93. PMID: 16781218 [PubMed - indexed for MEDLINE]

· De Caterina R, Zimarino M.:Coronary artery remodelling in atherosclerosis: unfortunately unpredictable. Eur Heart J. 2006 Aug;27(15):1761-3. Epub 2006 Jul 4. No abstract available. PMID: 16820366 [PubMed - in process]

· Madonna R, Rinaldi L, Rossi C, Geng YJ, De Caterina R.: Prostacyclin improves transcoronary myocardial delivery of adipose tissue-derived stromal cells. Eur Heart J. 2006 Sep;27(17):2054-61. Epub 2006 Jul 24. PMID: 16864608 [PubMed - in process]

· Zimarino M, Ausiello A, Contegiacomo G, Riccardi I, Renda G, Di Iorio C, De Caterina R.: Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions. J Am Coll Cardiol. 2006 Jul 4;48(1):59-65. Epub 2006 Jun 12. PMID: 16814649 [PubMed - indexed for MEDLINE]

· Kaloudi O, Basta G, Perfetto F, Bartoli F, Del Rosso A, Miniati I, Conforti ML, Generini S, Guiducci S, Abbate R, Pignone A, Castellani S, Livi R, De Caterina R, Matucci-Cerinic M.: Circulating levels of N{epsilon}- (carboxymethyl)lysine are increased in systemic sclerosis. Rheumatology (Oxford). 2006 Aug 27; [Epub ahead of print] PMID: 16936331 [PubMed - as supplied by publisher]

· Renda G, Tacconelli S, Capone ML, Sacchetta D, Santarelli F, Sciulli MG, Zimarino M, Grana M, D'Amelio E, Zurro M, Price TS, Patrono C, De Caterina R, Patrignani P.: Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. Clin Pharmacol Ther. 2006 Sep;80(3):264-74. PMID: 16952493 [PubMed - indexed for MEDLINE]

· Kardasz I, De Caterina R.: [Myocardial infarction with normal coronary arteries: a condition with multiple etiology and variable prognosis]. G Ital Cardiol (Rome). 2006 Jul;7(7):474-86. Review. Italian.

· Zimarino M, Prati F, Stabile E, Pizzicannella J, Fouad T, Filippini A, Rabozzi R, Trubiani O, Pizzicannella G, De Caterina R.: Optical coherence tomography accurately identifies intermediate atherosclerotic lesions- An in vivo evaluation in the rabbit carotid artery. Atherosclerosis. 2006 Sep 26; [Epub ahead of print]. PMID: 17007862 [PubMed - as supplied by publisher]

· Massaro M, Habib A, Lubrano L, Turco SD, Lazzerini G, Bourcier T, Weksler BB, De Caterina R.: The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC{epsilon} inhibition. Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15184-9. Epub 2006 Oct 3.

Butchart EG, Gohlke-Barwolf C, Renda G, De Caterina R. Antithrombotic management. In: Butchart EG, Gohlke-Barwolf C, Antunes MJ, Hall RJ, eds. Heart Valve Disease - a guide to patient management after surgery. Abingdon, UK: Informa Healthcare; 2006:83-109.
Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367(9526):1903-1912.
Connolly S, Yusuf S, Budaj A, Camm J, Chrolavicius S, Commerford PJ, Flather M, Fox KA, Hart R, Hohnloser S, Joyner C, Pfeffer M, Anand I, Arthur H, Avezum A, Bethala-Sithya M, Blumenthal M, Ceremuzynski L, De Caterina R, Diaz R, Flaker G, Frangin G, Franzosi MG, Gaudin C, Golitsyn S, Goldhaber S, Granger C, Halon D, Hermosillo A, Hunt D, Jansky P, Karatzas N, Keltai M, Lanas F, Lau CP, Le Heuzey JY, Lewis BS, Morais J, Morillo C, Oto A, Paolasso E, Peters RJ, Pfisterer M, Piegas L, Pipillis T, Proste C, Sitkei E, Swedberg K, Synhorst D, Talajic M, Tregou V, Valentin V, van Mieghem W, Weintraub W, Varigos J. Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. Am Heart J. 2006;151(6):1187-1193.
Crea F, Camici PG, De Caterina R, Lanza GA. Chronic Ischaemic Heart Disease. In: Camm AJ, Lüscher TF, Serruys PW, ESC, eds. The ESC Textbook of Cardiovascular Medicine: Blackwell Publishing Ltd; 2006:391-424.
De Caterina R. Antiatherogenic effects of n-3 fatty acids - evidence and mechanisms. Heart International. 2006;2(3-4):141-154.
De Caterina R, Pizzicannella G, Renda G, Zimarino M. Aneurisma coronarico: scoperta generalmente casuale, prognosi sempre severa? In: Prati PL, ed. Atti - Conoscere e Curare il Cuore 2006. Firenze: Centro per la lotta contro l'infarto - Fondazione Onlus; 2006:71-79.
De Caterina R, Renda G, Zimarino M. Terapia dell'infarto miocardico e delle sindromi coronariche. In: Tremoli E, Sirtori CS, Calabresi L, Franceschini G, eds. Basi farmacologiche della terapia cardiovascolare. Milano: Utet Scienze Mediche; 2006:294-328.
De Caterina R, Soccio M. Haemolysis after valve surgery. In: Butchart EG, Gohlke-Barwolf C, Antunes MJ, Hall RJ, eds. Heart Valve Disease - a guide to patient management after surgery. Abingdon, UK: Informa Healthcare; 2006:127-132.
De Caterina R, Zampolli A, Del Turco S, Madonna R, Massaro M. Nutritional mechanisms that influence cardiovascular disease. Am J Clin Nutr. 2006;83(2):421S-426S.
De Caterina R, Zimarino M. Coronary artery remodelling in atherosclerosis: unfortunately unpredictable. Eur Heart J. 2006;27(15):1761-1763.
Iachini Bellisarii F, Marchetti M, Caputo M, De Caterina R. Coronary arteriovenous fistula presenting as chronic pericardial effusion. J Cardiovasc Med (Hagerstown). 2006;7(6):449-453.
Kardasz I, De Caterina R. [Myocardial infarction with normal coronary arteries: a condition with multiple etiology and variable prognosis]. G Ital Cardiol (Rome). 2006;7(7):474-486.
Limbruno U, De Caterina R. EMERALD, AIMI, and PROMISE: is there still a potential for embolic protection in primary PCI? Eur Heart J. 2006;27(10):1139-1145.
Madonna R, Rinaldi L, Rossi C, Geng YJ, De Caterina R. Prostacyclin improves transcoronary myocardial delivery of adipose tissue-derived stromal cells. Eur Heart J. 2006;27(17):2054-2061.
Manes C, Giacci L, Sciartilli A, D'Alleva A, De Caterina R. Aspirin overprescription in primary cardiovascular prevention. Thromb Res. 2006;118(4):471-477.
Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, Weksler BB, De Caterina R. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci U S A. 2006;103(41):15184-15189.
Massaro M, Scoditti E, Carluccio MA, De Caterina R. Epidemiology of Olive Oil and Cardiovascular Disease. In: Quiles JL, Ramirez-Tortosa MC, Yaqoob P, eds. Olive Oil & Health. Wallingford, UK: Cabi; 2006:152-171.
Renda G, Tacconelli S, Capone ML, Sacchetta D, Santarelli F, Sciulli MG, Zimarino M, Grana M, D'Amelio E, Zurro M, Price TS, Patrono C, De Caterina R, Patrignani P. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. Clin Pharmacol Ther. 2006;80(3):264-274.

2007

Barnabei L, Marazia S, De Caterina R. Receiver operating characteristic (ROC) curves and the definition of threshold levels to diagnose coronary artery disease on electrocardiographic stress testing. Part I: The use of ROC curves in diagnostic medicine and electrocardiographic markers of ischaemia. J Cardiovasc Med (Hagerstown). 2007;8(11):873-881.
Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, Fox KA, Hasdai D, Ohman EM, Wallentin L, Wijns W, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Kristensen SD, Widimsky P, McGregor K, Sechtem U, Tendera M, Hellemans I, Gomez JL, Silber S, Funck-Brentano C, Kristensen SD, Andreotti F, Benzer W, Bertrand M, Betriu A, De Caterina R, Desutter J, Falk V, Ortiz AF, Gitt A, Hasin Y, Huber K, Kornowski R, Lopez-Sendon J, Morais J, Nordrehaug JE, Silber S, Steg PG, Thygesen K, Tubaro M, Turpie AG, Verheugt F, Windecker S. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J. 2007; 28(13): 1598-1660.
Carluccio MA, Ancora MA, Massaro M, Carluccio M, Scoditti E, Distante A, Storelli C, De Caterina R. Homocysteine induces VCAM-1 gene expression through NF-{kappa}B and NAD(P)H oxidase activation - protective role of Mediterranean diet polyphenolic antioxidants. Am J Physiol Heart Circ Physiol. 2007; 293(4): H2344-54.
Carluccio MA, Massaro M, Scoditti E, De Caterina R. Vasculoprotective potential of olive oil components. Mol Nutr Food Res. 2007;51(10):1225-1234.
De Caterina R. RAAS e aterosclerosi: un update. Paper presented at: Simposio "La prevenzione del danno vascolare: il ruolo del target pressorio e dei farmaci antiipertensivi" - 68° Congresso Nazionale della Società Italiana di Cardiologia; 17 dicembre, 2007; Roma.
De Caterina R, Husted S, Wallentin L, Agnelli G, Bachmann F, Baigent C, Jespersen J, Kristensen SD, Montalescot G, Siegbahn A, Verheugt FW, Weitz J. Anticoagulants in heart disease: current status and perspectives. Eur Heart J. 2007;28(7):880-913.
De Caterina R, Libby P, Gimbrone MA. Endothelial Dysfunctions and Vascular Disease: Blackwell Publishing; 2007.
De Caterina R, Madonna R. Sindrome metabolica: la grande madre della malattia vascolare? (con spunti sulla patogenesi). In: Prati PL, ed. Atti - Conoscere e Curare il Cuore 2008. Firenze: Centro per la lotta contro l'infarto - Fondazione Onlus; 2007:207-218.
De Caterina R, Madonna R, Bertolotto A, Schmidt EB. n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data. Diabetes Care. 2007;30(4):1012-1026.
De Caterina R, Massaro M. Mecanismos moleculares de los efectos antiateroscleroticos de los acidos grasos omega-3. Med Clin Monogr (Barc). 2007;8(2):31-39.
De Caterina R, Zampolli A. Omega-3 fatty acids, atherogenesis, and endothelial activation. J Cardiovasc Med (Hagerstown). 2007;8 Suppl 1:S11-14.
Del Turco S, Basta G, Lazzerini G, Evangelista M, Rainaldi G, Tanganelli P, Camera M, Tremoli E, De Caterina R. Parallel decrease of tissue factor surface exposure and increase of tissue factor microparticle release by the n-3 fatty acid docosahexaenoate in endothelial cells. Thromb Haemost. 2007;98(1):210-219.
Di Napoli P, Chierchia S, Taccardi AA, Grilli A, Felaco M, De Caterina R, Barsotti A. Trimetazidine improves post-ischemic recovery by preserving endothelial nitric oxide synthase expression in isolated working rat hearts. Nitric Oxide. 2007;16(2):228-236.
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte Op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Hellemans I, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgozoglu L, Wiklund O, Zampelas A. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28(19):2375-2414.
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgozoglu L, Wiklund O, Zampelas A. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14 Suppl 2:E1-40.
Husted S, Wallentin L, De Caterina R, disease' ObotTFotWGoTfAih. Management of pregnant women with artificial heart valves: inconsistency in ESC publications: reply. European Heart Journal. 2007.
Kaloudi O, Basta G, Perfetto F, Bartoli F, Del Rosso A, Miniati I, Conforti ML, Generini S, Guiducci S, Abbate R, Pignone A, Castellani S, Livi R, De Caterina R, Matucci-Cerinic M. Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. Rheumatology (Oxford). 2007;46(3):412-416.
Kardasz I, De Caterina R. Myocardial infarction with normal coronary arteries: a conundrum with multiple aetiologies and variable prognosis: an update. J Intern Med. 2007;261(4):330-348.
Madonna R, Massaro M, Pandolfi A, Consoli A, De Caterina R. The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. Int J Immunopathol Pharmacol. 2007;20(3):539-555.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosion E, Fagard R, Lindholm LH, Manolis A, Nilsson PM, Redon J, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Bertomeu V, Clement D, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL. [ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol. 2007;60(9):968 e961-994.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105-1187.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Kjeldsen SE, Erdine S, Narkiewicz K, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Cifkova R, Dominiczak A, Fagard R, Heagerty AM, Laurent S, Lindholm LH, Mancia G, Manolis A, Nilsson PM, Redon J, Schmieder RE, Struijker-Boudier HA, Viigimaa M, Filippatos G, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Kiowski W, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28(12):1462-1536.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Dalby Kristensen S, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Manolis A, Nilsson PM, Redon J, Viigimaa M. [Practice guidelines 2007 for the treatment of arterial hypertension]. G Ital Cardiol (Rome). 2007;8(7):389-479.
Massaro M, Scoditti E, Carluccio MA, Montinari MR, De Caterina R. Omega-3 Fatty Acids, Inflammation and Angiogenesis: Nutrigenomic Effects as an Explanation for Anti-atherogenic and Anti-inflammatory Effects of Fish and Fish Oils. Journal of Nutrigenetics and Nutrigenomics. 2007(1):4-23.
Renda G, Di Pillo R, D'Alleva A, Sciartilli A, Zimarino M, De Candia E, Landolfi R, Di Giammarco G, Calafiore A, De Caterina R. Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery. Haematologica. 2007;92(3):366-373.
Sjogren P, Basta G, de Caterina R, Rosell M, Basu S, Silveira A, de Faire U, Vessby B, Hamsten A, Hellenius ML, Fisher RM. Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men. Atherosclerosis. 2007;195(2):e168-175.
Tamburino C, Ussia GP, Zimarino M, Galassi AR, De Caterina R. Early restenosis after drug-eluting stent implantation: A putative role for platelet activation. Can J Cardiol. 2007;23(1):57-59.
Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, Schillaci G, De Caterina R. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension. 2007;50(2):325-332.
Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van Der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernandez-Aviles F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Sechtem U, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N. Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Eur Heart J. 2007;28(20):2525-2538.
Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernandez-Aviles F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634-2653.
Vanuzzo D, Pilotto L, Lombardi R, Lazzerini G, Carluccio M, Diviacco S, Quadrifoglio F, Danek G, Gregori D, Fioretti P, Cattaneo M, De Caterina R. Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects. Eur Heart J. 2007;28(4):484-491.
Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Priori SG, Blomstrom-Lundqvist C, Brignole M, Terradellas JB, Camm J, Castellano P, Cleland J, Farre J, Fromer M, Le Heuzey JY, Lip GY, Merino JL, Montenero AS, Ritter P, Schalij MJ, Stellbrink C. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Eur Heart J. 2007;28(18):2256-2295.
Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Priori SG, Blomstrom-Lundqvist C, Brignole M, Terradellas JB, Camm J, Castellano P, Cleland J, Farre J, Fromer M, Le Heuzey JY, Lip GY, Merino JL, Montenero AS, Ritter P, Schalij MJ, Stellbrink C. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Europace. 2007.
Zimarino M, Prati F, Stabile E, Pizzicannella J, Fouad T, Filippini A, Rabozzi R, Trubiani O, Pizzicannella G, De Caterina R. Optical coherence tomography accurately identifies intermediate atherosclerotic lesions--an in vivo evaluation in the rabbit carotid artery. Atherosclerosis. 2007;193(1):94-101.
Zimarino M, Renda G, De Caterina R. Triple antithrombotic therapy with aspirin, clopidogrel and warfarin--a persisting dilemma. Intern Emerg Med. 2007;2(3):163-164.

2008

Basta G, Berti S, Cocci F, Lazzerini G, Parri S, Papa A, Battaglia D, Lubrano V, Del Turco S, Ravani M, Rizza A, De Caterina R, Marraccini P, Mazzone A. Plasma N-ϵ-(carboxymethyl)lysine levels are associated with the extent of vessel injury after coronary arterial stenting. Coron Artery Dis. 2008;19(5):299-305.
De Carlo M, Maselli D, Cortese B, Ciabatti N, Gistri R, Levantino M, Balbarini A, De Caterina R, Petronio AS. Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors. Int J Cardiol. 2008;123(3):229-233.
De Caterina R. Rigenerazione del miocardio infartuato mediante stimolazione di cellule staminali indotta da microsfere biomimetiche. In: C.I.) CdSP-INplRC-CIINRC-, ed. 5° Workshop delle Unità Operative - Microsfere polimeriche e cellule staminali autologhe - Nuovi studi sulle possibilità di rigenerazione del miocardio infartuato. Vol Atti del Convegno. Torino: CLUEB 2008:67-71.
De Caterina R, Appignani M. Statine ad alte dosi e stent: il duello continua. In: Prati PL, ed. Atti - Conoscere e Curare il Cuore 2008. Firenze: Centro per la Lotta contro l'Infarto - Fondazione Onlus; 2008:253-271.
De Caterina R, Madonna R. Vascular Inflammation in diabetes mellitus. Nova Acta Leopoldina. 2008;NF 95(351):89-92.
De Caterina R, Renda G, Dalby-Kristensen S. New Anticoagulants for Atrial Fibrillation. E-journal of Cardiology Practice. Vol 7; 2008:1.
De Caterina R, Zoccali C. Dietary modulation of the inflammatory response. In: Wilcox CS, Berl T, Himmelfarb J, Mitch WE, Murphy B, Salant DJ, Yu ASL, eds. Therapy in nephrology and hypertension - a companion to Brenner & Rector's The Kidney. 3rd ed. Philadelphia: Saunders Elsevier; 2008:112-124.
Del Turco S, Basta G, Lazzerini G, Evangelista M, Rainaldi G, Tanganelli P, Christensen JH, Schmidt EB, De Caterina R. Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction. Haematologica. 2008;93(6):892-899.
Di Castelnuovo A, Soccio M, Iacoviello L, Evangelista V, Consoli A, Vanuzzo D, Diviacco S, Carluccio M, Rignanese L, De Caterina R. The C(242)T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and a meta-analysis. Thromb Haemost. 2008;99(3):594-601.
Di Stefano R, Barsotti MC, Melillo E, Iorio M, Santoni T, Armani C, Dell'omodarme M, Ristori C, De Caterina R, Balbarini A. The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia. Thromb Haemost. 2008;100(5):871-877.
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Tendera M, Auricchio A, Bax J, Bohm M, Corra U, Della Bella P, Elliott PM, Follath F, Gheorghiade M, Hasin Y, Hernborg A, Jaarsma T, Komajda M, Kornowski R, Piepoli M, Prendergast B, Tavazzi L, Vachiery JL, Verheugt FW, Zamorano JL, Zannad F. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008.
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Auricchio A, Bax J, Bohm M, Corra U, della Bella P, Elliott PM, Follath F, Gheorghiade M, Hasin Y, Hernborg A, Jaarsma T, Komajda M, Kornowski R, Piepoli M, Prendergast B, Tavazzi L, Vachiery JL, Verheugt FW, Zannad F. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10(10):933-989.
Genovesi E, Zimarino M, Renda G, De Caterina R. La tripla terapia con aspirina, clopidogrel e antagonisti della vitamina K: un problema ancora aperto. Cuore e Vasi. 2008;Anno XXX(3):23-25.
Healey JS, Hart RG, Pogue J, Pfeffer MA, Hohnloser SH, De Caterina R, Flaker G, Yusuf S, Connolly SJ. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Stroke. 2008;39(5):1482-1486.
Madonna R, Colella ME, De Caterina R. [Glycemic control in the coronary care unit: prognostic value and new therapeutic strategies]. G Ital Cardiol (Rome). 2008;9(9):603-614.
Madonna R, De Caterina R. In vitro neovasculogenic potential of resident adipose tissue precursors. Am J Physiol Cell Physiol. 2008;295(5):C1271-C1280
Madonna R, Massaro M, De Caterina R. Insulin potentiates cytokine-induced VCAM-1 expression in human endothelial cells. Biochim Biophys Acta - Molecular Basis of Disease. 2008;1782(9):511-516.
Marazia S, Barnabei L, De Caterina R. Receiver operating characteristic (ROC) curves and the definition of threshold levels to diagnose coronary artery disease on electrocardiographic stress testing. Part II: the use of ROC curves in the choice of electrocardiographic stress test markers of ischaemia. J Cardiovasc Med (Hagerstown). 2008;9(1):22-31.
Massaro M, Scoditti E, Carluccio M, De Caterina R. Le funzioni dell'endotelio. In: Cardiologia SId, ed. Manuale di Malattie Cardiovascolari. 31 Gennaio 2008 ed. ebook - on line: Centro Scientifico Editore; 2008.
Massaro M, Scoditti E, Carluccio MA, De Caterina R. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins Leukot Essent Fatty Acids. 2008;79(3-5):109-115.
Massaro M, Scoditti E, Carluccio MA, Montinari MR, De Caterina R. Omega-3 fatty acids, inflammation and angiogenesis: nutrigenomic effects as an explanation for anti-atherogenic and anti-inflammatory effects of fish and fish oils. J Nutrigenet Nutrigenomics. 2008;1(1-2):4-23.
Palmiero P, De Caterina R. Manuale di Elettrocardiografia Dinamica. Padova: Piccin Nuova Libraria Spa; 2008.
Patrignani P, Renda G, Tacconelli S, Capone M, Sacchetta D, Santarelli F, Sciulli M, Zimarino M, Grana M, D'Amelio E, Zurro M, Patrono C, De Caterina R. Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance". Clin Pharmacol Ther. 2008;83(6):812-813.
Prati F, Zimarino M, Stabile E, Pizzicannella G, Fouad T, Rabozzi R, Filippini A, Pizzicannella J, Cera M, De Caterina R. Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model. Heart. 2008;94(2):217-221.
Renda G, Zimarino M, De Caterina R. Dual antiplatelet strategies in patients requiring vitamin K antagonists. In: Angiolillo D, Kastrati A, Simon D, eds. Clinical Guide to the use of Antithrombotic Drugs in Coronary Artery Disease: Informa Healthcare; 2008:251-262.
Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galie N, Pruszczyk P, Bengel F, Brady AJ, Ferreira D, Janssens U, Klepetko W, Mayer E, Remy-Jardin M, Bassand JP, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Zamorano JL, Andreotti F, Ascherman M, Athanassopoulos G, De Sutter J, Fitzmaurice D, Forster T, Heras M, Jondeau G, Kjeldsen K, Knuuti J, Lang I, Lenzen M, Lopez-Sendon J, Nihoyannopoulos P, Perez Isla L, Schwehr U, Torraca L, Vachiery JL. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008;29(18):2276-2315.
Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di Mario C, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GY, Rutten F. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2008; 29(23): 2909-45.
Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Priori SG, Blomstrom-Lundqvist C, Brignole M, Terradellas JB, Camm J, Castellano P, Cleland J, Farre J, Fromer M, Le Heuzey JY, Lip GY, Merino JL, Montenero AS, Ritter P, Schalij MJ, Stellbrink C. [Guidelines for cardiac pacing and cardiac resynchronization therapy]. Rev Port Cardiol. 2008;27(5):639-687.
Zimarino M, De Caterina R. Long-term treatment strategies for atherothrombotic disease: do platelets define the course? Eur Heart J Suppl. 2008;10(Supplement I):I8-I13.
Zimarino M, Sacchetta D, Renda G, De Caterina R. Facilitated PCI: Rationale, Current Evidence, Open Questions, and Future Directions. J Cardiovasc Pharmacol. 2008;51(1):3-10.

2009

Madonna R, Geng YJ, De Caterina R. Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair. Arterioscler Thromb Vasc Biol. 2009;29(11):1723-1729.
Basta G, Leonardis D, Mallamaci F, Cutrupi S, Pizzini P, Gaetano L, Tripepi R, Tripepi G, De Caterina R, Zoccali C. Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease. Kidney Int.77(3):225-231.
De Caterina R. Controversia "I sartani: omogeneità di classe o specificità clinico-farmacologica?" - Il parere del cardiologo. Il Cardiologo. 2009;9(Suppl. al n. 1):1-4.
De Caterina R. The current role of anticoagulants in cardiovascular medicine. J Cardiovasc Med (Hagerstown). 2009;10(8):595-604.
De Caterina R, Madonna R. Cytochromes CYP1A1 and CYP1B1: new pieces in the puzzle to understand the biomechanical paradigm of atherosclerosis. Cardiovasc Res. 2009;81(4):629-632.
Zimarino M, De Caterina R. Drug-eluting balloons for percutaneous coronary interventions. Thromb Haemost. 2009;101(1):9-11.
Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360(20):2066-2078.
Madonna R, Shelat H, Xue Q, Willerson JT, De Caterina R, Geng YJ. Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-alpha. Exp Cell Res. 2009;315(17):2921-2928.
Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, Gorenek B, Hennerici MG, Iung B, Kelm M, Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe F, Pierard L, Ponikowski P, Schmid JP, Sellevold OF, Sicari R, Van den Berghe G, Vermassen F, Hoeks SE, Vanhorebeek I, Vahanian A, Auricchio A, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, McGregor K, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, De Caterina R, Agewall S, Al Attar N, Andreotti F, Anker SD, Baron-Esquivias G, Berkenboom G, Chapoutot L, Cifkova R, Faggiano P, Gibbs S, Hansen HS, Iserin L, Israel CW, Kornowski R, Eizagaechevarria NM, Pepi M, Piepoli M, Priebe HJ, Scherer M, Stepinska J, Taggart D, Tubaro M. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J. 2009; 30(22): 2769-812.
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Auricchio A, Bax J, Bohm M, Corra U, della Bella P, Elliott PM, Follath F, Gheorghiade M, Hasin Y, Hernborg A, Jaarsma T, Komajda M, Kornowski R, Piepoli M, Prendergast B, Tavazzi L, Vachiery JL, Verheugt FW, Zannad F. [Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008]. G Ital Cardiol (Rome). 2009;10(3):141-198; discussion 199-202.
Torbicki A, Perrier A, Konstantinides S, Agneli G, Galie N, Pruszczyk P, Bengel F, Brady AJ, Ferreira D, Janssens U, Klepetko W, Mayer E, Remy-Jardin M, Bassand JP, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Andreotti F, Ascherman M, Athanassopoulos G, De Sutter J, Fitzmaurice D, Forster T, Heras M, Jondeau G, Kjeldsen K, Knuuti J, Lang I, Lenzen M, Lopez-Sendon J, Nihoyannopoulos P, Perez Isla L, Schwehr U, Torraca L, Vachiery JL. [Guidelines on the diagnosis and management of acute pulmonary embolism]. Rev Port Cardiol. 2009;28(5):569-614.
Basta G, Castagnini M, Del Turco S, Epistolato MC, Righini P, Sangiorgi GM, De Caterina R, Tanganelli P. High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis. Eur J Clin Invest. 2009;39(12):1065-1072.
Lu L, Pu LJ, Zhang Q, Wang LJ, Kang S, Zhang RY, Chen QJ, Wang JG, De Caterina R, Shen WF. Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes. Atherosclerosis. 2009;206(2):540-545.
Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, Zembala M, Opolski G, Huber K, Arnesen H, Kristensen SD, De Caterina R. Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J. 2009;30(4):426-435.
De Caterina R, Malatesta G. La teoria infiammatoria dell'infarto: fatti e fantasie. In: Prati PL, ed. Atti - Conoscere e Curare il Cuore 2009. Firenze: ESSEBIEMME Editore; 2009:251-270.
Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di Mario C, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GY, Rutten F, Societa Europea di C. [Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. G Ital Cardiol (Rome). 2009;10(7):450-489.
De Caterina R, Kristensen SD, Renda G. New anticoagulants for atrial fibrillation. J Cardiovasc Med (Hagerstown). 2009;10(6):446-453.
Madonna R, De Caterina R. Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signalling. Thromb Haemost. 2009;101(2):345-350.
Lazzerini G, Turco SD, Basta G, O'Loghlen A, Zampolli A, De Caterina R. Prominent role of NF-kappaB in the induction of endothelial activation by endogenous nitric oxide inhibition. Nitric Oxide. 2009(21):184-191.
Zimarino M, De Caterina R. Qualche buona ragione per individuare la placca vulnerabile. In: Prati PL, ed. Atti - Conoscere e Curare il Cuore 2009. Firenze: ESSEBIEMME Editore; 2009:197-207.
Massaro M, Zampolli A, Scoditti E, Carluccio MA, Storelli C, Distante A, De Caterina R. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. Cardiovasc Res. 2009; 86(2): 311-320.
De Caterina R, Madonna R, Delli Pizzi S, Merla A, D'Ugo E, Rossi C, Tartaro A. Therapeutic potential of adipose tissue-derived stem/progenitor cells in a diabetic model of cardiomyopathy and hindlimb ischemia. Workshop delle unità operative dell'Istituto Nazionale per le Ricerche Cardiovascolari. Vol Atti del convegno. Parma; 2009:74-75.
Madonna R, De Caterina R. VEGF receptor switching in heart development and disease. Cardiovasc Res. 2009;84(1):4-6.

2010

De Caterina R, Madonna R. Impaired fasting plasma glucose and long-term cardiovascular risk: still a foggy relationship. Eur Heart J 2010; 31(19): 1159-1162.
De Caterina R, Scarano M, Marfisi R, Lucisano G, Palma F, Tatasciore A, Marchioli R. Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2010;55(3):198-211.
De Caterina R, Zimarino M. Understanding the complexity of abciximab-related thrombocytopenia. Thromb Haemost 2010;103(3):484-486.
Madonna R, De Caterina R. Adipose tissue: a new source for cardiovascular repair. J Cardiovasc Med (Hagerstown)2010;11(2):71-80.
Madonna R, Rokosh G, De Caterina R, Bolli R. Hepatocyte growth factor/Met gene transfer in cardiac stem cells--potential for cardiac repair. Basic Res Cardiol 2010;105(4):443-452.
Massaro M, Scoditti E, Carluccio MA, Campana MC, De Caterina R. Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils. Cell Mol Biol (Noisy-le-grand)2010; 56(1):59-82.
Massaro M, Zampolli A, Scoditti E, Carluccio MA, Storelli C, Distante A, De Caterina R. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. Cardiovasc Res 2010;86(2):311-320.
Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, Gorenek B, Hennerici MG, Iung B, Kelm M, Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe F, Pierard L, Ponikowski P, Schmid JP, Sellevold OF, Sicari R, Van den Berghe G, Vermassen F, Hoeks SE, Vanhorebeek I, Vahanian A, Auricchio A, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearn P, McDonag T, McGregor K, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, De Caterina R, Agewall S, Al Attar N, Andreotti F, Anker SD, Baron-Esquivias G, Berkenboom G, Chapoutot L, Cifkova R, Faggiano P, Gibbs S, Hansen HS, Iserin L, Israel CW, Kornowski R, Eizagaechevarria NM, Pepi M, Piepoli M, Priebe HJ, Scherer M, Stepinska J, Taggart D, Tubaro M. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 2010;27(2):92-137.
Renda G, Zurro M, Romano M, De Caterina R. Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors. Br J Clin Pharmacol 2010;69(3):303-306.
Scoditti E, Massaro M, Carluccio MA, Distante A, Storelli C, De Caterina R. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium. Cardiovasc Res 2010;86(2):302-310.
Zimarino M, Barnabei L, De Caterina R. 'Missing' coronary arteries at urgent coronary angiography for ST-elevation myocardial infarction. J Cardiovasc Med (Hagerstown) 2010.
Zimarino M, Ruggieri B, De Caterina R. Towards a tailored use of eluted drugs for percutaneous coronary interventions. Circ J 2010;74(3):424-425.